These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8453506)

  • 81. Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice.
    Ramanadham S; Yarasheski KE; Silva MJ; Wohltmann M; Novack DV; Christiansen B; Tu X; Zhang S; Lei X; Turk J
    Am J Pathol; 2008 Apr; 172(4):868-81. PubMed ID: 18349124
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cyclooxygenase-2 inhibitor reduces simvastatin-induced bone morphogenetic protein-2 and bone formation in vivo.
    Bradley JD; Cleverly DG; Burns AM; Helm NB; Schmid MJ; Marx DB; Cullen DM; Reinhardt RA
    J Periodontal Res; 2007 Jun; 42(3):267-73. PubMed ID: 17451547
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ--prostaglandin E2 dependent proliferation of growth plate chondrocytes.
    Brochhausen C; Neuland P; Kirkpatrick CJ; Nüsing RM; Klaus G
    Arthritis Res Ther; 2006; 8(3):R78. PubMed ID: 16646980
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Type I collagen synthesis and degradation in peritendinous tissue after exercise determined by microdialysis in humans.
    Langberg H; Skovgaard D; Petersen LJ; Bulow J; Kjaer M
    J Physiol; 1999 Nov; 521 Pt 1(Pt 1):299-306. PubMed ID: 10562353
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Mechanotransduction and the functional response of bone to mechanical strain.
    Duncan RL; Turner CH
    Calcif Tissue Int; 1995 Nov; 57(5):344-58. PubMed ID: 8564797
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dietary lipids, prostaglandin E2 levels, and tooth movement in alveolar bone of rats.
    Kokkinos PP; Shaye R; Alam BS; Alam SQ
    Calcif Tissue Int; 1993 Nov; 53(5):333-7. PubMed ID: 8287321
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Chronic intramedullary infusion of interleukin-1 alpha increases bone mineral content in rats.
    Takada M; Yamamoto I; Morita R
    Calcif Tissue Int; 1994 Aug; 55(2):103-8. PubMed ID: 7953974
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Increased bone growth by local prostaglandin E2 in rats.
    Yang RS; Liu TK; Lin-Shiau SY
    Calcif Tissue Int; 1993 Jan; 52(1):57-61. PubMed ID: 8453506
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Anabolic responses of an adult cancellous bone site to prostaglandin E2 in the rat.
    Ito H; Ke HZ; Jee WS; Sakou T
    Bone Miner; 1993 Jun; 21(3):219-36. PubMed ID: 8400921
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The role of bone cells in increasing metaphyseal hard tissue in rapidly growing rats treated with prostaglandin E2.
    Jee WS; Ueno K; Kimmel DB; Woodbury DM; Price P; Woodbury LA
    Bone; 1987; 8(3):171-8. PubMed ID: 3475073
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats.
    Lin BY; Jee WS; Ma YF; Ke HZ; Kimmel DB; Li XJ
    Bone; 1994; 15(5):489-96. PubMed ID: 7980959
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The effects of prostaglandin E2 in rapidly growing rats: depressed longitudinal and radial growth and increased metaphyseal hard tissue mass.
    Ueno K; Haba T; Woodbury D; Price P; Anderson R; Jee WS
    Bone; 1985; 6(2):79-86. PubMed ID: 3860213
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Long-term low-dose prostaglandin E1 administration.
    Sone K; Tashiro M; Fujinaga T; Tomomasa T; Tokuyama K; Kuroume T
    J Pediatr; 1980 Nov; 97(5):866-7. PubMed ID: 7431186
    [No Abstract]   [Full Text] [Related]  

  • 94. Prostaglandin-induced periostitis: a complication of long-term PGE1 infusion in an infant with congenital heart disease.
    Ringel RE; Brenner JI; Haney PJ; Burns JE; Moulton AL; Berman MA
    Radiology; 1982 Mar; 142(3):657-8. PubMed ID: 7199748
    [No Abstract]   [Full Text] [Related]  

  • 95. Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.
    Ueda K; Saito A; Nakano H; Aoshima M; Yokota M; Muraoka R; Iwaya T
    J Pediatr; 1980 Nov; 97(5):834-6. PubMed ID: 7000997
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.